T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RWT
676
Redwood Trust
RWT
$602M
| $80.9M | 0.02% |
4,525,365
-394,160
| -8% | -$7.64M |
|
|
TIF
677
DELISTED
Tiffany & Co.
TIF
| $80.8M | 0.02% |
917,849
-508,407
| -36% | -$45.5M |
|
678
Capital One
COF
$137B
| $79.8M | 0.02% |
1,012,356
+20,710
| +2% | +$1.63M |
|
|
GMCR
679
DELISTED
KEURIG GREEN MTN INC
GMCR
| $79.5M | 0.02% |
711,463
+214,715
| +43% | +$26.8M |
|
|
ESGR
680
DELISTED
Enstar Group
ESGR
| $79.3M | 0.02% |
558,684
+9,346
| +2% | +$1.31M |
|
681
Hexcel
HXL
$7.69B
| $79M | 0.02% |
1,537,076
+10,270
| +0.7% | +$471K |
|
|
CVT
682
DELISTED
CVENT, INC.
CVT
| $78.5M | 0.02% |
2,800,516
+584,980
| +26% | +$16M |
|
683
Selective Insurance
SIGI
$5.64B
| $78.5M | 0.02% |
2,701,790
+24,060
| +0.9% | +$662K |
|
684
Advanced Energy
AEIS
$13.5B
| $78.3M | 0.02% |
3,052,070
-201,240
| -6% | -$5.12M |
|
|
PE
685
DELISTED
PARSLEY ENERGY INC
PE
| $77.8M | 0.02% |
4,867,521
+717,971
| +17% | +$11.2M |
|
686
Prudential Financial
PRU
$42.8B
| $77.7M | 0.02% |
967,310
+10,400
| +1% | +$842K |
|
687
Perrigo
PRGO
$1.8B
| $77.5M | 0.02% |
467,957
-215,721
| -32% | -$34.4M |
|
|
IMS
688
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
| $77.4M | 0.02% |
2,859,040
+525,950
| +23% | +$13.6M |
|
689
Ares Capital
ARCC
$14.4B
| $77.4M | 0.02% |
4,506,840
-803,860
| -15% | -$13.4M |
|
690
Ultragenyx Pharmaceutical
RARE
$2.61B
| $77.4M | 0.02% |
1,245,840
-70,300
| -5% | -$3.9M |
|
|
LTRPA
691
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $76.8M | 0.02% |
2,417,054
+19,000
| +0.8% | +$549K |
|
692
Intuit
INTU
$94.7B
| $76.8M | 0.02% |
791,701
+37,253
| +5% | +$3.46M |
|
|
SPTN
693
DELISTED
SpartanNash
SPTN
| $76.3M | 0.02% |
2,417,390
-581,960
| -19% | -$15.7M |
|
|
MRO
694
DELISTED
Marathon Oil Corporation
MRO
| $76.3M | 0.02% |
2,920,908
-4,663,413
| -61% | -$127M |
|
|
ALEX
695
DELISTED
Alexander & Baldwin
ALEX
| $76.3M | 0.02% |
1,766,082
+206,700
| +13% | +$8.2M |
|
696
American Eagle Outfitters
AEO
$2.73B
| $76.1M | 0.02% |
4,453,690
-925,220
| -17% | -$14.1M |
|
|
HSNI
697
DELISTED
HSN, Inc.
HSNI
| $76M | 0.02% |
1,114,574
+54,260
| +5% | +$3.82M |
|
698
Norfolk Southern
NSC
$76.2B
| $75.8M | 0.02% |
736,637
-79,865
| -10% | -$8.54M |
|
699
Veeco
VECO
$3.29B
| $75.7M | 0.02% |
2,478,070
+522,143
| +27% | +$16.3M |
|
|
BFS
700
Saul Centers
BFS
$861M
| $75M | 0.02% |
1,311,459
-264,205
| -17% | -$14.9M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.